EchoStar Soars; US Steel Rallies; Sarpeta Plunges

On this episode of Stock Movers:
- EchoStar (SATS) is soaring this morning as President Trump urges the company to make a deal with the FCC for its wireless spectrum licenses. The president met with EchoStar Chairman Charlie Ergen and Carr at the White House, encouraging them to work together and reach a deal. The FCC is investigating whether EchoStar is meeting obligations for its wireless and satellite spectrum rights, and the company has been skipping bond coupon payments and considering filing for bankruptcy.
- US Steel (X) is rallying today as Nippon Steel secured approval from President Trump to purchase United States Steel Corp. for $14.1 billion, its biggest ever overseas bet. The deal comes with significant concessions to the US government, including a "golden share" that gives Washington a say in major decisions and control over some board seats, and a promise to invest $14 billion over the coming years.
- Roche (RHHBY) is slightly down, but its partner Sarpeta Therapeutics (SRPT) is plunging on news that a second patient has died of acute liver failure while being treated with Sarepta Therapeutics Inc.'s gene therapy for a rare muscle disorder, following a similar death three months prior. The development has cast a pall over Sarpeta's most important drug and will intensify scrutiny on the FDA over its decision to approve it, despite a lack of data showing it slows overall progression of the disease.
- Victoria's Secret (VSCO) is up on news Barington Capital Group has built a stake in Victoria's Secret & Co. and plans to urge changes to its board and strategy. The company is under pressure to grow sales amid new competition, and its shares have declined 56% this year through Friday. The company has faced challenges, including tariffs, weakening consumer spending, and a security incident that took its e-commerce operation offline, affecting its goal to regain dominance in bras.

See omnystudio.com/listener for privacy information.